Samuel Waksal

(redirected from Samuel D. Waksal)
Also found in: Medical, Wikipedia.

Samuel Waksal

Founder of ImClone, a pharmaceutical company in the United States. While serving as CEO in 2002, he was arrested for insider trading, eventually pleading guilty to securities fraud and similar charges. This scandal was noted for also leading to the arrest of noted television personality Martha Stewart. Waksal was born in 1947.
References in periodicals archive ?
patents gives ImClone and Abbott, a strong proprietary position for RCR technology worldwide," stated Samuel D.
The claims against all defendants would be dismissed with prejudice but the Company would retain the right to continue to pursue certain claims against its former chief executive officer, Samuel D.
3 million, an amount representing the withholding tax liability attributable to Samuel D.
ImClone Systems Incorporated (NASDAQ:IMCL), today announced that Samuel D.
We will be working closely with the FDA toward the goal of an expeditious acceptance of our BLA," stated Samuel D.
We are very pleased to join the ranks of the world's most impressive entrepreneurial companies," commented Samuel D.
The timely accomplishment of this most important milestone is a reflection of the Company's commitment to bring this very important product candidate to patients as quickly as possible," stated Samuel D.